Sarepta Therapeutics (SRPT) Cash from Operations (QoQ) (2010 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Sarepta Therapeutics | 1.86 Bn | 1.17 Bn | 291.52 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -254.48% |
| Dec 31, 2025 | 999.60% |
| Sep 30, 2025 | -105.58% |
| Jun 30, 2025 | 144.79% |
| Mar 31, 2025 | -733.85% |
| Dec 31, 2024 | 230.19% |
| Sep 30, 2024 | -573.16% |
| Jun 30, 2024 | 106.17% |
| Mar 31, 2024 | -342.90% |
| Dec 31, 2023 | 52.35% |
| Sep 30, 2023 | 6.16% |
| Jun 30, 2023 | 41.63% |
| Mar 31, 2023 | -126.64% |
| Dec 31, 2022 | -42.22% |
| Sep 30, 2022 | 2.77% |
| Jun 30, 2022 | 33.96% |
| Mar 31, 2022 | -245.00% |
| Dec 31, 2021 | 76.41% |
| Sep 30, 2021 | -13.91% |
| Jun 30, 2021 | 39.49% |
| Mar 31, 2021 | -3.34% |
| Dec 31, 2020 | 26.72% |
| Sep 30, 2020 | -121.36% |
| Jun 30, 2020 | -117.14% |
| Mar 31, 2020 | 483.28% |
| Dec 31, 2019 | -142.91% |
| Sep 30, 2019 | 14.65% |
| Jun 30, 2019 | 45.97% |
| Mar 31, 2019 | -19.45% |
| Dec 31, 2018 | -8.03% |
| Sep 30, 2018 | 3.36% |
| Jun 30, 2018 | -228.74% |
| Mar 31, 2018 | -14.84% |
| Dec 31, 2017 | 46.36% |
| Sep 30, 2017 | 32.00% |
| Jun 30, 2017 | -47.09% |
| Mar 31, 2017 | 28.74% |
| Dec 31, 2016 | -34.01% |
| Sep 30, 2016 | -40.04% |
| Jun 30, 2016 | 28.68% |
| Mar 31, 2016 | -94.06% |
| Dec 31, 2015 | 32.48% |
| Sep 30, 2015 | -62.33% |
| Jun 30, 2015 | 34.18% |
| Mar 31, 2015 | -70.33% |
| Dec 31, 2014 | 27.95% |
| Sep 30, 2014 | 10.59% |
| Jun 30, 2014 | -39.76% |
| Mar 31, 2014 | -58.60% |
| Dec 31, 2013 | 10.34% |
| Sep 30, 2013 | -65.62% |
| Jun 30, 2013 | 19.95% |
| Mar 31, 2013 | -109.46% |
| Dec 31, 2012 | 8.29% |
| Sep 30, 2012 | -37.36% |
| Jun 30, 2012 | 37.21% |
| Mar 31, 2012 | -60.22% |
| Dec 31, 2011 | 24.92% |
| Sep 30, 2011 | -1,602.04% |
| Jun 30, 2011 | 95.61% |
| Mar 31, 2011 | -433.16% |
| Dec 31, 2010 | 31.91% |